To improve the prognosis of metastatic TNBC patients, antibodydrug conjugates (ADCs), such as sacituzumab govitecan, have been utilized to specifically deliver potent chemotherapy agents directly to cancer cells expressing targeted antigens, demonstrating promising efficacy [25]
Higher levels of this bacterium were associated with better physical wellbeing, mood, sleep quality, and lower anxiety (Evans et al., 2017)
Several studies have shown that IF can modulate oxidative stress and inflammatory pathways, but much of this research has focused on the general population or individuals with metabolic syndrome 9,10
This compound is handled in controlled settings for in vitro and pre-clinical studies, with no applications in human or veterinary medicine